| ID | 1106 |
| Name of the vaccine | ORC-Vax |
| Microbe | Bacteria |
| Disease name | Cholera |
| Name of bacteria | Vibrio cholerae |
| Type of vaccine | Inactivated |
| Nucleic acid content | DNA |
| Age | 1 year and older |
| Description of the vaccine | Oral killed OCV containing V. cholerae O1 cells without the cholera toxin B (CTB) subunit. Licensed only in Vietnam. |
| Name of the manufacturer | Vabiotech, Hanoi |
| Name of the manufacturing country | Vietnam |
| Year of manufacture | 1997 |
| Clinical Phase status | Approved |
| Bacterial strain | Gram-negative bacteria. |
| Efficacy | Moderate (58%) short-term (4–6-month) protection, 60% for 2 years and was present (42%) during the third year of follow-up. |
| Vaccine formulation | NA |
| Dosage | Two doses, gap of 14 days. |
| Mechanism of action | NA |
| Route of administration | Oral |
| Indications | NA |
| Export | Not for international use |
| Approval | Not WHO prequalified. |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | 21498389 |
| Clinical trial number | NA |
| Reference | https://www.who.int/bulletin/volumes/92/12/14-139949.pdf?ua=1 |
| Other name | NA |
| Additional Links | NA
|